The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of zoptarelin doxorubicin in castration- and taxane-resistant prostate cancer.
 
Steven Yu
No Relationships to Disclose
 
Kanthi Athreya
No Relationships to Disclose
 
Stephen V. Liu
Consulting or Advisory Role - ARIAD; Biodesix; Boehringer Ingelheim; Caris Life Sciences; Genentech; Perthera; Pfizer
 
Andrew V. Schally
Research Funding - Ferring
Patents, Royalties, Other Intellectual Property - University of Miami (Inst)
 
Susan G. Groshen
No Relationships to Disclose
 
Denice D Tsao-Wei
No Relationships to Disclose
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Tanya B. Dorff
Honoraria - Astellas Pharma; Dendreon; Medivation; Pfizer
Consulting or Advisory Role - Bayer; Dendreon; Genentech
Speakers' Bureau - Astellas Pharma; Dendreon; Pfizer
Research Funding - Bristol-Myers Squibb
 
Shigang Xiong
No Relationships to Disclose
 
Jacek Pinski
Speakers' Bureau - Amgen; Astellas Oncology; Bayer; Dendreon; Janssen Oncology
Patents, Royalties, Other Intellectual Property - CBI
 
Jurgen Engel
Employment - AEterna Zentaris
Leadership - AEterna Zentaris
Stock and Other Ownership Interests - AEterna Zentaris
Travel, Accommodations, Expenses - AEterna Zentaris